Back to company

VIAD PHARMA ApS: Financial statements 2020

CVR: 36433892

VIAD PHARMA ApS (CVR 36433892) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,290,916 and a net result of DKK 457,510 compared with DKK 554,640 the year before. That is a decrease of 8.5% compared with the year before. Equity amounted to DKK 525,877. The solvency ratio was 29.7%.

Gross Profit
1,290,916 kr.
Profit/Loss
457,510 kr.
Equity
525,877 kr.
Total Assets
1,768,231 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.3 mio.458 t.526 t.-
2019-1.4 mio.555 t.668 t.-
2018-1.4 mio.553 t.714 t.-
2017-1.5 mio.677 t.761 t.-
2016-1.4 mio.623 t.684 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is VIAD PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

VIAD PHARMA ApS: The 2019 annual report is outAug 28, 2020

VIAD PHARMA ApS has published its annual report for 2019. Gross profit came to DKK 1,410,155, and the net result was DKK 554,640.

About VIAD PHARMA ApS

VIAD PHARMA ApS is a Danish company of the type Anpartsselskab based in København NV, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The management consists of Heidi Meier. The company is owned by HEIDI MEIER HOLDING ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 1,031,002 and a net result of DKK 168,032 compared with DKK 808,813 the year before. Equity amounted to DKK 236,399.